Mark F. Prummel

9.1k citations

77 papers · 6.0k indexed · 3 hit papers · h-index 36

Pathology and Forensic Medicine top 0.1%
- Ophthalmology and Eye Disorders 46
Endocrinology, Diabetes and Metabolism top 0.2%
- Pituitary Gland Disorders and Treatments 31
- Thyroid Disorders and Treatments 19
- Growth Hormone and Insulin-like Growth Factors 8
- Adrenal Hormones and Disorders 8
Ophthalmology top 0.2%
- Glaucoma and retinal disorders 25
- Ocular Oncology and Treatments 5
Neurology top 1%
Pediatrics, Perinatology and Child Health top 2%
Physiology
- Erythrocyte Function and Pathophysiology 4

Co-authors: Wilmar M. Wiersinga Maarten P. Mourits Leo Koornneef Martin N. Gerding Arie Berghout Caroline B. Terwee Iris M.M.J. Wakelkamp Friedo W. Dekker
Cited by: Pathology and Forensic Medicine Endocrinology, Diabetes and Metabolism Ophthalmology
Journals: The Journal of Clinical Endocrinology & Metabolism (10 papers)Thyroid (8 papers)Clinical Endocrinology (8 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

Mark F. Prummel

75 papers receiving 5.8k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2011 New England Journal of Medicine
1997 Clinical Endocrinology
1989 British Journal of Ophthalmology

Peers

Countries citing papers authored by Mark F. Prummel

Since Specialization

Citations

This map shows the geographic impact of Mark F. Prummel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark F. Prummel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark F. Prummel more than expected).

Fields of papers citing papers by Mark F. Prummel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark F. Prummel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark F. Prummel. The network helps show where Mark F. Prummel may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark F. Prummel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark F. Prummel Line = papers co-authored together Mark F. Prummel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Reactivation of Graves’ Orbitopathy after Rehabilitative Orbital Decompression Ophthalmology ·Lelio Baldeschi,Antonella Lupetti,Yuebing Gao,Iris M.M.J. Wakelkamp,Mark F. Prummel,Wilmar M. Wiersinga	2007	51
2	Establishment of reference values for endocrine tests--part V: acromegaly. PubMed ·Erik Endert,Yolanda Guevara Ben Tez,Eric Fliers,Mark F. Prummel,W M Wiersinga	2006	9
3	A reduced IL2R (CD25) expression level in first and second degree female relatives of autoimmune thyroid disease patients. A sign of a poor capability to preserve tolerance? Autoimmunity ·Thea G. A. Strieder,Hemmo A. Drexhage,Georgia Künecke,Mark F. Prummel,Jan G.P. Tijssen,Wilmar M. Wiersinga	2006	9
4	Thyroid peroxidase autoantibodies in euthyroid subjects Best Practice & Research Clinical Endocrinology & Metabolism ·Mark F. Prummel,Wilmar M. Wiersinga	2005	138
5	The Removal of the Deep Lateral Wall in Orbital Decompression: Its Contribution to Exophthalmos Reduction and Influence on Consecutive Diplopia American Journal of Ophthalmology ·Lelio Baldeschi,Sourabh Aditya Swarnkar,Christoph Hintschich,Iris M.M.J. Wakelkamp,Mark F. Prummel,Wilmar M. Wiersinga	2005	76
6	Stress is not associated with thyroid peroxidase autoantibodies in euthyroid women Brain Behavior and Immunity ·Thea G. A. Strieder,Mark F. Prummel,Jan G.P. Tijssen,J. F. Brosschot,Wilmar M. Wiersinga	2004	18
7	Thyrotropin Receptor Autoantibodies Are Associated with Continued Thyrotropin Suppression in Treated Euthyroid Graves’ Disease Patients The Journal of Clinical Endocrinology & Metabolism ·Leon J. S. Brokken,Wilmar M. Wiersinga,Mark F. Prummel	2003	21
8	Graves’ ophthalmopathy: a rational approach to treatment Trends in Endocrinology and Metabolism ·Wilmar M. Wiersinga,Mark F. Prummel	2002	56
9	AN EVIDENCE-BASED APPROACH TO THE TREATMENT OF GRAVES' OPHTHALMOPATHY Endocrinology and Metabolism Clinics of North America ·Wilmar M. Wiersinga,Mark F. Prummel	2000	30
10	Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters Clinical Endocrinology ·Martin N. Gerding,Mark F. Prummel,Wilmar M. Wiersinga	2000	47
11	Octreotide‐scintigraphy is a disease‐activity parameter in Graves' ophthalmopathy Clinical Endocrinology ·Martin N. Gerding,Friso M. van der Zant,Eric A. van Royen,Leo Koornneef,E. P. Krenning,W. M. Wiersinga,Mark F. Prummel	1999	55
12	Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL British Journal of Ophthalmology ·Caroline B. Terwee,Martin N. Gerding,Friedo W. Dekker,Mark F. Prummel,Wilmar M. Wiersinga	1998	217
13	Quality of Life in Patients with Graves' Ophthalmopathy is Markedly Decreased: Measurement by the Medical Outcomes Study Instrument Thyroid ·Martin N. Gerding,Caroline B. Terwee,Friedo W. Dekker,Leo Koornneef,Mark F. Prummel,Wilmar M. Wiersinga	1997	164
14	The effect of long-term prednisone treatment on growth hormone and insulin-like growth factor-I Journal of Endocrinological Investigation ·Mark F. Prummel,Wilmar M. Wiersinga,Hans Oosting,E Endert	1996	26
15	Molecular cloning and characterization of human thyroid peroxidase autoantibodies of lambda light chain type Molecular Immunology ·S Portolano,Mark F. Prummel,Basil Rapoport,Sandra M. McLachlan	1995	26
16	Randomised double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathy The Lancet ·Mark F. Prummel,Arie Berghout,Wilmar M. Wiersinga,Maarten P. Mourits,Leo Koornneef,L. Blank	1993	235
17	Beclomethasone inhalation decreases serum osteocalcin concentrations. BMJ ·E.M. Pouw,Mark F. Prummel,Hans Oosting,Carolyn M Roos,Erik Endert	1991	132
18	Bilateral adrenal tumours in primary aldosteronism: localization of a unilateral aldosteronoma by dexamethasone suppression scan Journal of Internal Medicine ·B. Caralp,Mark F. Prummel,M.M.C. Tiel-van Buul	1991	12
19	HLA-DR4 associated response to corticosteroids in Graves’ ophthalmopathy patients Journal of Endocrinological Investigation ·R. van der Gaag,Wilmar M. Wiersinga,Leo Koornneef,Maarten P. Mourits,Mark F. Prummel,Arie Berghout,René R. P. de Vries,G. M. T. Schreuder,J. D’Amaro	1990	4
20	Thrombosis Prophylaxis in an AT III Deficient Pregnant Woman: Application of a Low Molecular Weight Heparinoid Thrombosis and Haemostasis ·Ch. P. Henny,Hugo Ten Cate,J W ten Cate,Mark F. Prummel,Marjolein Peters,Harry R. Büller	1986	32

About Mark F. Prummel

Mark F. Prummel is a scholar working on Ophthalmology, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 77 papers that have together received 6.0k indexed citations. Recurring topics across this work include Ophthalmology and Eye Disorders (46 papers), Pituitary Gland Disorders and Treatments (31 papers), Glaucoma and retinal disorders (25 papers), Thyroid Disorders and Treatments (19 papers), Growth Hormone and Insulin-like Growth Factors (8 papers), Adrenal Hormones and Disorders (8 papers), Ocular Oncology and Treatments (5 papers) and Erythrocyte Function and Pathophysiology (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (4.4k citations), Endocrinology, Diabetes and Metabolism (3.6k citations) and Ophthalmology (1.6k citations). Mark F. Prummel has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Wilmar M. Wiersinga, Maarten P. Mourits, Leo Koornneef, Martin N. Gerding, Arie Berghout, Caroline B. Terwee, Iris M.M.J. Wakelkamp, Friedo W. Dekker, R. van der Gaag and Onno Bakker. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Thyroid, Clinical Endocrinology, Clinical & Experimental Immunology and Ophthalmology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact